XML 64 R53.htm IDEA: XBRL DOCUMENT v3.10.0.1
Discontinued Operations - Key Financial Results (Details) - Infectious Disease Business - Disposal Group, Disposed of by Sale, Not Discontinued Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]        
Net product revenues $ 0 $ 9,003 $ (107) $ 23,635
Operating expenses:        
Cost of product revenue 0 5,314 197 12,681
Research and development 24 12,761 534 34,566
Selling, general and administrative (80) 13,433 2,997 57,400
Total operating expenses (56) 31,508 3,728 104,647
Loss from operations 56 (22,505) (3,835) (81,012)
Gain from sale of business 0 0 168,955 0
Other income (expense), net (52) (452) 358 (820)
Income (loss) from discontinued operations before income taxes 4 (22,957) 165,478 (81,832)
Benefit for income taxes 4,003 0 55,236 2
Income (loss) from discontinued operations, net of tax $ (3,999) $ (22,957) $ 110,242 $ (81,834)